Overview
Precision Cancer Medicine, published by AME Publishing Company (Hong Kong), published 128 papers in 2021–2025, and its papers received 416 citations in those years. Its h-index is 13 and its two-year mean citedness is 2.50. On the ITS Journal Score it ranks #16,215 of 62,158 ranked journals and #3,476 of 8,757 in Medicine.
Key figures
Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.
Papers and citations by year
| Year | Papers | Citations received | Open-access papers |
|---|---|---|---|
| 2020 | 45 | 151 | 35 |
| 2021 | 71 | 246 | 49 |
| 2022 | 34 | 116 | 34 |
| 2023 | 17 | 39 | 17 |
| 2024 | 5 | 14 | 5 |
| 2025 | 1 | 1 | 0 |
What it publishes
The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.
Similar journals
Ranked journals that publish on the same topics.
| Journal | Field | Score | Papers 2021–2025 | Open access |
|---|---|---|---|---|
| Clinical Lung Cancer | Medicine | 73.3 | 849 | 41% |
| Lung Cancer Targets and Therapy | Medicine | 58.0 | 70 | 100% |
| JTO Clinical and Research Reports | Medicine | 64.1 | 679 | 100% |
| Journal of Thoracic Oncology | Medicine | 74.8 | 10,750 | 61% |
| Translational Lung Cancer Research | Medicine | 73.3 | 1,620 | 100% |
| Lung Cancer | Medicine | 74.7 | 3,096 | 25% |
| Thoracic Cancer | Medicine | 72.6 | 2,099 | 100% |
| Cancer Treatment and Research Communications | Medicine | 62.9 | 757 | 100% |
Compare with similar journals (side by side with the two closest journals above)
Identity and sources
- ISSN-L: 2617-2216
- Print ISSN: 2617-2216
- Publisher: AME Publishing Company
- Listed in DOAJ: Not yet checked
- Crossref: Not yet checked
- OpenAlex: S4210229884
- Journal website: pcm.amegroups.com
Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.
Questions
What is the ITS Journal Score of Precision Cancer Medicine?
It is 54.8 out of 100, which places it #16,215 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.
What is the impact factor of Precision Cancer Medicine?
This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 2.50.
Is Precision Cancer Medicine open access?
82% of its papers from 2021–2025 are recorded as open access.
Does Precision Cancer Medicine charge a publication fee?
No fee is recorded in the open data used here. Check the journal's own website for its current fees.